Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 25, 2016	Sep. 27, 2015
Cash flows from operating activities
Net earnings	$ 352,552	$ 272,478
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation of plant and equipment	89,327	86,393
Amortization of intangibles	26,073	35,330
Program production cost amortization	17,501	29,812
Deferred income taxes	25,091	(10,236)
Stock-based compensation	39,673	33,073
Change in operating assets and liabilities:
Decrease (Increase) in accounts receivable	(224,172)	(382,573)
Decrease (Increase) in inventories	(214,734)	(156,221)
Decrease (Increase) in prepaid expenses and other current assets	(4,063)	39,521
Program Production Costs	(36,010)	(28,222)
Increase (Decrease) in accounts payable and accrued liabilities	129,661	165,632
Other	(47,118)	(15,429)
Net cash provided by operating activities	153,781	69,558
Cash flows from investing activities
Additions to property, plant and equipment	(103,639)	(97,873)
Cash proceeds from dispositions	0	18,632
Investment and acquisitions, net of cash acquired	(12,436)	(3,000)
Other	25,576	23,447
Net cash utilized by investing activities	(90,499)	(58,794)
Cash flows from financing activities
Net (repayments of) proceeds from other short-term borrowings	14,160	(138,101)
Purchases of common stock	(104,273)	(74,110)
Stock option transactions	37,515	33,929
Excess tax benefits from stock-based compensation	19,712	9,804
Dividends paid	(185,265)	(168,393)
Other financing activities	762	928
Net cash utilized by financing activities	(217,389)	(335,943)
Effect of exchange rate changes on cash	7,729	(16,696)
Increase (Decrease) in cash and cash equivalents	(146,378)	(341,875)
Cash and cash equivalents at beginning of year	976,750	893,167
Cash and cash equivalents at end of period	830,372	551,292
Cash paid during the period for:
Interest	74,700	78,056
Income taxes	$ 64,854	$ 80,833